Triple 000 and Sub-penny Chart Plays

[cazual]

SVFC $$$$ Oversold, undervalued...huge potential...Perfect storm!

http://stockcharts.com/h-sc/ui?s=SVFC&p=D&yr=0&mn=5&dy=0&id=p00939244863

https://investorshub.advfn.com/secure/priv.aspx?r=http%3a%2f%2fstockcharts.com%2fc-sc%2fsc%3fs%3dSVFC%26amp%3bp%3dD%26amp%3byr%3d0%26amp%3bmn%3d3%26amp%3bdy%3d0%26amp%3bi%3dp05687233441%26amp%3ba%3d334736635%26amp%3br%3d1397351383969

THREE International Patents pending...one in Final Stage of Grant with two to follow, a positive International written preliminary opinion by the Patent Cooperation Treaty for all three core requirements; Novelty, Inventive Step and Industrial Applicability!...and the US Patented Stem Cell Technology verified by Millipore:)...and....yet more amazing progress... the Hong Kong patent application has recently been published in the EPO! http://ih.advfn.com/p.php?pid=nmona&article=61697331

Recently appointed Clinical Research Organization (CRO), InVentive Clinical, is ANOTHER STRATEGIC DEVELOPMENT to facilitate clinical trials and IND application for SVFC's patented technology in the research and treatment of knee osteoarthritis at the Andrews' Research and Education Foundation.
http://ih.advfn.com/p.php?pid=nmona&article=61836784

Licensing agreement with the internationally known Andrews's Research and Educational Foundation, as well as the IND to be filed for Knee Osteoarthritis, is a strategic move to position SVFC Patented Stem Cell Technology as the golden standard in the area of orthopedic/sports and regenerative medicine:)
http://ih.advfn.com/p.php?pid=nmona&article=61427219
http://www.theandrewsinstitute.com/InjuryPrevention/STOPSportsInjuries.aspx

Filing an IND for research and treatment of knee osteoarthritis in a consulting agreement with Dr. Anz and Dr. Hackel of the Andrews's Research and Education Foundation, will enable SVFC's patented stem cell tech to treat orthopedic and sports medicine injuries in compliance with the FDA.
http://ih.advfn.com/p.php?pid=nmona&article=61476597

Collaboration with the Global Alliance for Innovation in Neuroscience to utilize SVFC patented Stem Cell technology for the treatment of autism, dementia, brain trauma and neurological disorders will bring international recognition to Intellicell.
http://ih.advfn.com/p.php?pid=nmona&article=61509178

Research collaboration with Dr. Trujillo to develop clinical studies in the treatment of ALS using Intellicell's SVF cells and conducted under an Investigational New Drug Application will provide new found hope for individuals afflicted with the debilitating effects of ALS.
http://ih.advfn.com/p.php?pid=nmona&article=61566989
http://ih.advfn.com/p.php?pid=nmona&article=61612564

http://patentscope.wipo.int/search/en/detail.jsf?docId=WO2014036094&recNum=1&office=&queryString=FP%3A%28intellicell%29&prevFilter=&sortOption=Pub+Date+Desc&maxRec=7

http://patentscope.wipo.int/search/en/detail.jsf?docId=WO2012091911&recNum=4&office=&queryString=FP%3A%28intellicell+Biosciences%29&prevFilter=&sortOption=Pub+Date+Desc&maxRec=6

https://register.epo.org/application?number=EP11854049&lng=en&tab=event

http://pericles.ipaustralia.gov.au/ols/auspat/applicationDetails.do?applicationNo=2011352928

http://ih.advfn.com/p.php?pid=nmona&article=59699971

As the new Chairman of the IntelliCell Orthopedic Cellular Therapy Advisory Board, Dr. James Andrews stated, "We at the Andrews's Research and Educational Foundation have recently joined forces with Intelicell BioSciences to participate in their autologous stem cell research. We are excited at the opportunity of developing a first class biological laboratory at our facility in conjunction with Intelicell BioSciences that will allow us to continue our effort towards excellence in clinical stem cell therapy research."
http://ih.advfn.com/p.php?pid=nmona&article=61427219

Dr. James Andrews said, "We are excited that we will have the opportunity to work with inVentiv Clinical Health as the CRO for our IND study of osteoarthritis of the knee using IntelliCell's technology. It will be research like this at the Andrews' Research and Educational Institute in collaboration with IntelliCell BioSciences and inVentiv that will further our research in the use of the biologics for the treatment of the osteoarthritic knee. We believe, based on antidotal evidence of others, that this cellular therapy has the potential to be a game changer."
http://ih.advfn.com/p.php?pid=nmona&article=61836784

According to Sandlin Lowe, MD, Co-Founder and Director of GAIN and Consulting Clinician to the Amen Clinics New York, "Dr. Victor's approach to stem cell treatments is revolutionary. The IntelliCell BioSciences / GAIN collaboration will expand the use of autologous mesenchymal stem cells derived by sonification of the stromal vascular fraction of adipose tissue for many neuropsychiatric conditions including autism, dementia and brain injury."

"We at GAIN look forward to an exciting and fruitful collaboration with IntelliCell BioSciences as together we pioneer new methods in translational neuroscience for the imaging and treatment of autism, Alzheimer's dementia, and brain blast injuries," says Dr. Lowe.
http://ih.advfn.com/p.php?pid=nmona&article=61509178

As said by Dr. Adam Anz, "Dr. Victor, through Intellicell Biosciences, has been a pioneer in the clinical application of stem cell therapy in the United States. His interactions with the FDA have helped us understand the current regulatory status, and he has a practice, which recently has passed their scrutiny. At the Andrews Research and Education Institute, we look forward to collaborating with him and to applying his technology in a compliant fashion. Working together we will produce evidence about the value of stem cell therapy for the treatment of joint injuries and degeneration, which will help us treat our patients better."

According to Dr. Josh Hackel, "We have recognized IntelliCell BioSciences as a forward thinking company and we are excited to continue FDA compliant research in this area as it relates to sports medicine and the treatment of our patients. It will be research like this at the Andrews Research and Education Institute in collaboration with IntelliCell BioSciences that will further our understanding and improve our management of sports medicine injuries."
http://ih.advfn.com/p.php?pid=nmona&article=61476597

As per Dr. Zain Khalpey, cardiac surgeon and member of SVFC's advisory board, "I would rather not put you on the list for transplant, I would rather take your fat-derived stem cells, inject them into you and try to use the device as a bridge to regenerate your heart, rather than using transplanted tissue, where you have to be on immunosuppression for the rest of your life. I believe that with the use of cavitation technology to harvest the stromal vascular fraction from a lipoaspirate without chemicals and enzymes, we would be able to capture the appropriate stem cells with their micromatrix and microenvironment for use in patients with failing hearts and lungs."

http://www.marketwatch.com/story/intellicell-biosciences-announces-that-dr-zain-khalpey-has-joined-its-advisor
http://surgery.arizona.edu/faculty-profile/zain-khalpey-md-phd-mrcs